MAIA Biotechnology Inc (MAIA)
3.28
+0.16
(+5.13%)
USD |
NYAM |
May 17, 16:00
3.28
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology Shareholders Equity (Quarterly): -5.765M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -5.765M |
| December 31, 2023 | 0.4775M |
| September 30, 2023 | 2.748M |
| June 30, 2023 | 6.874M |
| March 31, 2023 | 5.083M |
| Date | Value |
|---|---|
| December 31, 2022 | 8.508M |
| September 30, 2022 | 12.33M |
| June 30, 2022 | 6.662M |
| March 31, 2022 | 9.014M |
| December 31, 2021 | 9.181M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-5.765M
Minimum
Mar 2024
12.33M
Maximum
Sep 2022
5.511M
Average
6.768M
Median
Shareholders Equity (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 0.607M |
| Avid Bioservices Inc | 180.17M |
| Oragenics Inc | 3.168M |
| NeuBase Therapeutics Inc | 9.137M |
| Viking Therapeutics Inc | 933.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.716M |
| Total Liabilities (Quarterly) | 14.48M |